Ponatinib

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

9 Suppliers, 3 USDMF, 3 EU WC, 4 NDC API, 6 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

6 Drug(s) in Development

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

20 Dossiers, 6 FDA Orange Book, 7 Europe, 1 Canada, 6 Australia

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 17 Kerry, 9 Microlex e.U, 9 Sigachi Industries, 7 Roquette, 7 Gangwal Healthcare, 4 Gangwal Chemicals, 4 DFE Pharma, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Vasa Pharmachem, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Prachin Chemical, 1 SPI Pharma, 1 Ideal Cures Pvt Ltd, 1 Nanjing Well Pharmaceutical, 1 Pharmatrans-Sanaq

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 15 Direct Compression, 11 Lubricants & Glidants, 10 Thickeners and Stabilizers, 9 Co-Processed Excipients, 8 Granulation, 6 Disintegrants & Superdisintegrants, 4 Controlled & Modified Release, 2 Taste Masking, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers, 1 Parenteral

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

3 APIs, 2 DOSSIERS // FDF

PATENTS

68 US Patents, 4 US Exclusivities, 2 Health Canada Patents

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 34 News

Information, Expiry & Status of Health Canada Patents covering Ponatinib.

Ponatinib

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

9 Suppliers

3 USDMF

3 EU WC

4 NDC API

6 Listed Suppliers

DEVELOPMENTS

6 Drug(s) in Development

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

20 Dossiers

6 FDA Orange Book

7 Europe

1 Canada

6 Australia

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 15MG BASE

TABLET;ORAL - EQ 30MG BASE

TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

17 Kerry

9 Microlex e.U

9 Sigachi Industries

7 Roquette

7 Gangwal Healthcare

4 Gangwal Chemicals

4 DFE Pharma

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Vasa Pharmachem

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Prachin Chemical

1 SPI Pharma

1 Ideal Cures Pvt Ltd

1 Nanjing Well Pharmaceutical

1 Pharmatrans-Sanaq

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

15 Direct Compression

11 Lubricants & Glidants

10 Thickeners and Stabilizers

9 Co-Processed Excipients

8 Granulation

6 Disintegrants & Superdisintegrants

4 Controlled & Modified Release

2 Taste Masking

2 Emulsifying Agents

2 Chewable & Orodispersible Aids

2 Coating Systems & Additives

1 Film Formers & Plasticizers

1 API Stability Enhancers

1 Rheology Modifiers

1 Parenteral

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

4 Finished Drug Prices

MARKET PLACE

3 APIs

2 DOSSIERS // FDF

PATENTS

68 US Patents

4 US Exclusivities

2 Health Canada Patents

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

34 News

Ponatinib

Borden Ladner Gervais

Ponatinib

2634923

15 mg

TABLET

Human

2026-12-22